Spectral AI (MDAI) Profit After Tax Growth (1y) (2022 - 2026)
Spectral AI (MDAI) Profit After Tax Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 12.92% |
| 10 | Spectral AI | 50.69 Mn | 36.69 Mn | 1.11 Mn | 47.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.58% |
| Mar 31, 2026 | -217.78% |
| Dec 31, 2025 | 114.36% |
| Sep 30, 2025 | -136.17% |
| Jun 30, 2025 | -178.21% |
| Mar 31, 2025 | 190.39% |
| Dec 31, 2024 | -113.90% |
| Sep 30, 2024 | 85.85% |
| Jun 30, 2024 | 6.71% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | -103.91% |
| Sep 30, 2023 | -2,697.89% |
| Jun 30, 2023 | -1,058.49% |
| Mar 31, 2023 | -583.52% |
| Dec 31, 2022 | 62.96% |
| Sep 30, 2022 | -117.06% |
| Jun 30, 2022 | 90.87% |
| Mar 31, 2022 | -116.39% |